DOCSLIB.ORG

University of Florida Thesis Or Dissertation Formatting

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
University of Florida Thesis Or Dissertation Formatting IDENTIFICATION OF GENETIC PREDICTORS OF RESISTANT HYPERTENSION THROUGH GENOME WIDE ASSOCIATION ANALYSIS COUPLED WITH INDUCED PLURIPOTENT STEM CELLS By NIHAL EL ROUBY A DISSERTATION PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY UNIVERSITY OF FLORIDA 2017 © 2017 Nihal El Rouby To my family, My mother Camilia, My father Mohammed El Rouby, My husband Ihab and sons Yaseen and Yousef, My brother Ameer, My sisters Iman, Sara and Heba, My friends Amira Khalil, Maha El badry and Amira Sirag ACKNOWLEDGMENTS I would like to give my sincere gratitude to my mentor, Dr. Julie Johnson, for her mentorship, guidance, and continuous support throughout my PhD training. I cannot thank her enough for providing me the opportunity to work in her lab and under her supervision. Her continuous support and mentoring helped me grow and become a better researcher. I learned from her how to think critically of all the details in the research and how to criticize my own work. I believe that any success in my career will be attributed to her continuous teaching, encouragement and support. I can say that I owe her a debt of gratitude for all she has done to help me succeed in my PhD and thereafter. I would like to thank all my committee members for their continuous guidance and extended support along the way. I am especially grateful to Dr. Caitrin McDonough who taught me everything about genetic analysis. She has been supportive since the very first day I joined the Johnson’s lab. She was always there whenever I wanted to consult and communicate any difficulties that I encounter during my analysis. Her feedback and valuable input have certainly helped me accomplish my project successfully. I would like to thank Dr. Yan Gong, for her tremendous help and support to my study and specifically the statistical aspects of the project. Special thanks Dr. Naohiro Terada who welcomed me in his lab and provided all the support and help me to learn and grasp a very new field to me. I would also like to thank Dr. Jefferey Harrison for his advices and insights on the CX3CR1 project. Dr. Harrison has always made time to discuss and support different aspects of my project. Special thanks to Dr. Matthew Gitzendanner for all his help, guidance and support, especially in the bioinformatics analysis. He always provided help whenever I needed and was always 4 willing to help me troubleshoot some of my codes that never worked. I would like to thank Dr. Jatinder lamba for her valuable advice, input and support for my work during my PhD training. I would like to also thank Dr. Mark Wallet for his advice and input on the monocytes differentiation and CX3CR1. My sincerest gratitude goes to Dr. Taimour Langaee, Dr. Rhonda Copper- DeHoff, Dr. Larissa Cavallari, and Dr. Reggie Frye for their support, valuable advice, and help during my PhD. Special thanks to Dr. Carl Pepine for giving me the opportunity to participate in the resistant hypertension clinic during my training, and for his continuous support. My utmost gratitude also goes to Dr. Katherine Santostefano who taught me everything about iPSC and wet lab experiments. Thank you for your gracious help and support throughout my project. I would also like to thank Dr. Nikolette Biel, Dr. Sonal Singh, Dr. Natalie Fredette, Dr. Noriko Watanabe, Dr. Chul Han, and Bayli DiVita for all their help with the iPSC project. They have been supportive to my experience in the Terada’s lab. I would like to thank Dr. Charles Wood in the department of Physiology and Functional Genomics for his continuous support throughout my PhD. I must acknowledge NIH grant T32HL083810 and the Department of Physiology and Functional Genomics for support of my PhD training. I would like to extend a special thanks to all present and former graduate students and postdocs in the Department of Pharmacotherapy and Translational Research who have been a family for me. Special thanks to Dr. Mohamed Mohamed Eslam who has graciously helped me when I first came her to UF. Dr. Mohamed and his 5 wife, Rana have been a family to me. Special thanks to Dr. Mohamed Hossam Shahin who has been always a brother to me. Dr. Mohamed Shahin has never hesitated in helping me and answering any questions I have. Special thanks to my colleague, Carol Sa, who started her PhD journey at the same time. Carol has been always there to support me during my journey. Special thanks to Dr. Issam Hamadeh, Dr. Shin-wen Chang, Dr. Mohamed Solayman, Dr. Sonal Singh for their kindness, support and friendship. I would also like to extend my thanks to Ben Burkley, Cheryl Galloway, Lynda Stauffer, who facilitated part of the research in this dissertation. I would like to deeply thank my wonderful husband – Ihab– for his tremendous support, love, caring, patience and encouragement; without his support, the completion of my PhD would have never been possible. I would like to thank my sons, Yaseen and Yousef, for the joy they have created in my life. They always kept me going as I have wanted be a role model for them when they grow up. I would like to dedicate my great and sincere thanks to my best friend Amira Khalil, who has been always a motivation force for me. Special thanks to my friends Maha El Badry and Amira Sirag who have always supported me and made this journey pleasant. Special thanks to my friends, Yasmeen Magdy, Amal Bakry, Razan Alfakir, Nadia Salloom and Souad Benchemsi for their kindness and support. Last, but not least, I would like to thank my family members, my father, Dr. El Rouby, who has been a role model for me. He taught me, by example, the importance of hard work, humbleness and selflessness. My mother has always showered me with unconditional love, support and encouragement. My brother and sisters have 6 surrounded me with care and support throughout every stage of my life; without your support, I would have never accomplished any of my goals. 7 TABLE OF CONTENTS page ACKNOWLEDGMENTS .................................................................................................. 4 LIST OF TABLES .......................................................................................................... 12 LIST OF FIGURES ........................................................................................................ 13 ABSTRACT ................................................................................................................... 15 CHAPTER 1 GENETICS OF RESISTANT HYPERTENSION – A NOVEL PHARMACOGENOMICS PHENOTYPE ................................................................. 18 Introduction ............................................................................................................. 18 Recent RHTN Pharmacogenetics Studies........................................................ 20 Genetic Variation in Sodium and Water Handling Pathways ............................ 21 1) Epithelial Sodium Channel (ENAC) ....................................................... 21 2) Aldosterone synthase (Cytochrome P45011B2, CYP11B2) .................. 22 3) Cytochrome P450, family 4, subfamily A, polypeptide 11, CYP4A11 .... 23 Genetic Variation Affecting Response to Dietary Salt Reduction and Diuretics ........................................................................................................ 24 -Adducin ................................................................................................. 24 Guanine nucleotide-binding protein -polypeptide 3 (GNB3) ..................... 25 Neural precursor cell expressed developmentally down – regulated 4- like (NEDD4L) ......................................................................................... 25 Recent Genetic Studies in RHTN ..................................................................... 26 Genes related to vascular function ............................................................. 26 eNos variants and phosphodiesterase type 5 inhibitors ............................. 28 RHTN Associations in Genes of Unrelated Pathways ...................................... 29 Need for Expansive Genetic Approaches in RHTN Pharmacogenomics.......... 32 Conclusions ............................................................................................................ 37 Significance ............................................................................................................ 38 2 QUALITY CONTROL AND IMPUTATION PROCEDURES FOR THE SECONDARY PREVENTION OF SUBCORTICAL STROKES DATASET ............. 42 Introduction ............................................................................................................. 42 Methods .................................................................................................................. 45 Tools and software used for QC and imputation .............................................. 45 Study participants ............................................................................................. 45 Secondary Prevention of Subcortical Strokes (SPS3) ...................................... 45 Genotyping ....................................................................................................... 45 Per marker QC procedures .............................................................................. 45 8 SNP genotyping call rate and removing SNPs below the missingness call rate ................................................................................................................ 46 SNP deviating from Hardy
Load more

Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2015/0072349 A1 Diamandis Et Al
    US 201500 72349A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2015/0072349 A1 Diamandis et al. (43) Pub. Date: Mar. 12, 2015 (54) CANCER BOMARKERS AND METHODS OF (52) U.S. Cl. USE CPC. G0IN33/57484 (2013.01); G0IN 2333/705 (2013.01) (71) Applicant: University Health Network, Toronto USPC ......................................... 435/6.12: 435/7.94 (CA) (57) ABSTRACT A method of evaluating a probability a Subject has a cancer, (72) Inventors: Eleftherios P. Diamandis, Toronto diagnosing a cancer and/or monitoring cancer progression (CA); Ioannis Prassas, Toronto (CA); comprising: a. measuring an amount of a biomarker selected Shalini Makawita, Toronto (CA); from the group consisting of CUZD1 and/or LAMC2 and/or Caitlin Chrystoja, Toronto (CA); Hari the group CUZD1, LAMC2, AQP8, CELA2B, CELA3B, M. Kosanam, Maple (CA) CTRB1, CTRB2, GCG, IAPP, INS, KLK1, PNLIPRP1, PNLIPRP2, PPY, PRSS3, REG3G, SLC30A8, KLK3, NPY, (21) Appl. No.: 14/385,449 PSCA, RLN1, SLC45A3, DSP GP73, DSG2, CEACAM7, CLCA1, GPA33, LEFTY1, ZG16, IRX5, LAMP3, MFAP4, (22) PCT Fled: Mar. 15, 2013 SCGB1A1, SFTPC, TMEM100, NPY, PSCA RLN1 and/or SLC45A3 in a test sample from a subject with cancer; (86) PCT NO.: PCT/CA2O13/OOO248 wherein the cancer is pancreas cancer if CUZD1, LAMC2, S371 (c)(1), AQP8, CELA2B, CELA3B, CTRB1, CTRB2, GCG, LAPP (2) Date: Sep. 23, 2014 INS, KLK1, PNLIPRP1, PNLIPRP2, PPY, PRSS3, REG3G, SLC30A8, DSP GP73 and/or DSG2 is selected; the cancer is colon cancer if CEACAM7, CLCA1, GPA33, LEFTY 1 and/ Related U.S. Application Data or ZG16 is selected, the cancer is lung cancer if IRX5, (60) Provisional application No.
    [Show full text]
  • Specificity of a Polyclonal Fecal Elastase ELISA for CELA3
    RESEARCH ARTICLE Specificity of a Polyclonal Fecal Elastase ELISA for CELA3 Frank Ulrich Weiss, Christoph Budde, Markus M. Lerch* University Medicine Greifswald, Department of Medicine A, Ferdinand Sauerbruch-Str., D-17475 Greifswald, Germany * [email protected] a11111 Abstract Introduction Elastase is a proteolytic pancreatic enzyme that passes through the gastrointestinal tract undergoing only limited degradation. ELISA tests to determine stool elastase concentra- tions have therefore been developed for the diagnosis of exocrine pancreatic insufficiency. OPEN ACCESS Five different isoforms of pancreatic elastase (CELA1, CELA2A, CELA2B, CELA3A, Citation: Weiss FU, Budde C, Lerch MM (2016) CELA3B) are encoded in the human genome. We have investigated three different poly- Specificity of a Polyclonal Fecal Elastase ELISA for CELA3. PLoS ONE 11(7): e0159363. doi:10.1371/ clonal antisera that are used in a commercial fecal elastase ELISA to determine their speci- journal.pone.0159363 ficity for different pancreatic elastase isoforms. Editor: Keping Xie, The University of Texas MD Anderson Cancer Center, UNITED STATES Material and Methods Received: October 9, 2015 Different polyclonal rabbit antisera against human elastase peptides (BIOSERV Diagnos- Accepted: July 2, 2016 tics GmbH, Germany) were tested by Western blot analysis of human pancreatic juice, in HEK-293 cells expressing Elastase constructs, and in the protein content of porcine pancre- Published: July 26, 2016 atin, used for treatment of exocrine pancreatic insufficiency. Copyright: © 2016 Weiss et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits Results unrestricted use, distribution, and reproduction in any In human pancreatic juice the polyclonal antisera detected proteins at the corresponding medium, provided the original author and source are size of human pancreatic elastase isoforms (~29kDa).
    [Show full text]
  • Single Cell Derived Clonal Analysis of Human Glioblastoma Links
    SUPPLEMENTARY INFORMATION: Single cell derived clonal analysis of human glioblastoma links functional and genomic heterogeneity ! Mona Meyer*, Jüri Reimand*, Xiaoyang Lan, Renee Head, Xueming Zhu, Michelle Kushida, Jane Bayani, Jessica C. Pressey, Anath Lionel, Ian D. Clarke, Michael Cusimano, Jeremy Squire, Stephen Scherer, Mark Bernstein, Melanie A. Woodin, Gary D. Bader**, and Peter B. Dirks**! ! * These authors contributed equally to this work.! ** Correspondence: [email protected] or [email protected]! ! Supplementary information - Meyer, Reimand et al. Supplementary methods" 4" Patient samples and fluorescence activated cell sorting (FACS)! 4! Differentiation! 4! Immunocytochemistry and EdU Imaging! 4! Proliferation! 5! Western blotting ! 5! Temozolomide treatment! 5! NCI drug library screen! 6! Orthotopic injections! 6! Immunohistochemistry on tumor sections! 6! Promoter methylation of MGMT! 6! Fluorescence in situ Hybridization (FISH)! 7! SNP6 microarray analysis and genome segmentation! 7! Calling copy number alterations! 8! Mapping altered genome segments to genes! 8! Recurrently altered genes with clonal variability! 9! Global analyses of copy number alterations! 9! Phylogenetic analysis of copy number alterations! 10! Microarray analysis! 10! Gene expression differences of TMZ resistant and sensitive clones of GBM-482! 10! Reverse transcription-PCR analyses! 11! Tumor subtype analysis of TMZ-sensitive and resistant clones! 11! Pathway analysis of gene expression in the TMZ-sensitive clone of GBM-482! 11! Supplementary figures and tables" 13" "2 Supplementary information - Meyer, Reimand et al. Table S1: Individual clones from all patient tumors are tumorigenic. ! 14! Fig. S1: clonal tumorigenicity.! 15! Fig. S2: clonal heterogeneity of EGFR and PTEN expression.! 20! Fig. S3: clonal heterogeneity of proliferation.! 21! Fig.
    [Show full text]
  • Downloaded from the CAVA Integration with Data Generated by Pre-NGS Methods Webpage [19]
    Münz et al. Genome Medicine (2015) 7:76 DOI 10.1186/s13073-015-0195-6 METHOD Open Access CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting Márton Münz1†, Elise Ruark2†, Anthony Renwick2, Emma Ramsay2, Matthew Clarke2, Shazia Mahamdallie2,3, Victoria Cloke3, Sheila Seal2,3, Ann Strydom2,3, Gerton Lunter1 and Nazneen Rahman2,3,4* Abstract Background: Next-generation sequencing (NGS) offers unprecedented opportunities to expand clinical genomics. It also presents challenges with respect to integration with data from other sequencing methods and historical data. Provision of consistent, clinically applicable variant annotation of NGS data has proved difficult, particularly of indels, an important variant class in clinical genomics. Annotation in relation to a reference genome sequence, the DNA strand of coding transcripts and potential alternative variant representations has not been well addressed. Here we present tools that address these challenges to provide rapid, standardized, clinically appropriate annotation of NGS data in line with existing clinical standards. Methods: We developed a clinical sequencing nomenclature (CSN), a fixed variant annotation consistent with the principles of the Human Genome Variation Society (HGVS) guidelines, optimized for automated variant annotation of NGS data. To deliver high-throughput CSN annotation we created CAVA (Clinical Annotation of VAriants), a fast, lightweight tool designed for easy incorporation into NGS pipelines. CAVA allows transcript specification, appropriately accommodates the strand of a gene transcript and flags variants with alternative annotations to facilitate clinical interpretation and comparison with other datasets. We evaluated CAVA in exome data and a clinical BRCA1/BRCA2 gene testing pipeline.
    [Show full text]
  • Functional Genomic Annotation of Genetic Risk Loci Highlights Inflammation and Epithelial Biology Networks in CKD
    BASIC RESEARCH www.jasn.org Functional Genomic Annotation of Genetic Risk Loci Highlights Inflammation and Epithelial Biology Networks in CKD Nora Ledo, Yi-An Ko, Ae-Seo Deok Park, Hyun-Mi Kang, Sang-Youb Han, Peter Choi, and Katalin Susztak Renal Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania ABSTRACT Genome-wide association studies (GWASs) have identified multiple loci associated with the risk of CKD. Almost all risk variants are localized to the noncoding region of the genome; therefore, the role of these variants in CKD development is largely unknown. We hypothesized that polymorphisms alter transcription factor binding, thereby influencing the expression of nearby genes. Here, we examined the regulation of transcripts in the vicinity of CKD-associated polymorphisms in control and diseased human kidney samples and used systems biology approaches to identify potentially causal genes for prioritization. We interro- gated the expression and regulation of 226 transcripts in the vicinity of 44 single nucleotide polymorphisms using RNA sequencing and gene expression arrays from 95 microdissected control and diseased tubule samples and 51 glomerular samples. Gene expression analysis from 41 tubule samples served for external validation. 92 transcripts in the tubule compartment and 34 transcripts in glomeruli showed statistically significant correlation with eGFR. Many novel genes, including ACSM2A/2B, FAM47E, and PLXDC1, were identified. We observed that the expression of multiple genes in the vicinity of any single CKD risk allele correlated with renal function, potentially indicating that genetic variants influence multiple transcripts. Network analysis of GFR-correlating transcripts highlighted two major clusters; a positive correlation with epithelial and vascular functions and an inverse correlation with inflammatory gene cluster.
    [Show full text]
  • Role of Chymotrypsin-Like Elastase 1 in Lung Physiology and in Α1-Antitrypsin Deficiency
    bioRxiv preprint doi: https://doi.org/10.1101/138776; this version posted May 16, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Role of Chymotrypsin-like Elastase 1 in Lung Physiology and in α1-Antitrypsin Deficiency Authors: Rashika Joshi1a, Andrea Heinz2;3†, Qiang Fan1a, Shuling Guo4, Brett Monia4, Christian E.H. Schmelzer2,5, Anthony S. Weiss6a-c, Matthew Batie1b, Harikrishnan Parameswaran7, Brian M. Varisco*1a,8 Affiliations: 1-Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio a-Division of Critical Care Medicine b-Division of Clinical Engineering 2-Martin Luther University, Halle-Wittenberg, Germany 3-University of Copenhagen, Copenhagen, Denmark 4-Ionis Pharmaceuticals, Carlsbad, California 5-Fraunhofer Institute for Microstructure of Materials and Systems IMWS, Freiburg, Germany 6-University of Sydney, Sydney, Australia a-Charles Perkins Centre b-Life and Environmental Sciences c-Bosch Institute 7-Northeastern University Department of Biomedical Engineering, Boston, Massachusetts 8-Univeristy of Cincinnati Department of Pediatrics, Cincinnati, Ohio † Co-first Author * Corresponding Author. [email protected]. SUMMARY α1-antitrypsin (AAT) deficiency-related emphysema is the fourth leading indication for lung transplantation. We previously demonstrated that AAT covalently neutralizes chymotrypsin-like elastase 1 (Cela1) in vitro, that Cela1 is expressed during the alveolar stage of lung development in association with regions of lung elastin remodeling, and that lung stretch increases Cela1 expression and binding to lung elastin. Here we show that Cela1 is exclusively responsible for stretch-inducible lung elastase activity, reduces postnatal lung elastance, and is required for emphysema in an antisense oligo model of AAT deficiency.
    [Show full text]
  • The Role of Elastases in Pancreatic Diseases
    The role of elastases in pancreatic diseases Ph.D. Thesis Anna Zsófia Tóth M.D. Supervisors: Prof. Péter Hegyi, M.D., Ph D., D.Sc. Prof. Miklós Sahin-Tóth, M.D., Ph.D., D.Sc Doctoral School of Theoretical Medicine Szeged 2018. Content Content ....................................................................................................................................... 1 1. List of abbreviations ........................................................................................................... 3 2. Introduction ......................................................................................................................... 5 2.1. Exocrin pancreatic insufficiency ................................................................................. 5 2.2. Pancreatic elastases ...................................................................................................... 5 2.3. Pancreatic function tests based on detection of elastases ............................................ 7 2.4. Possible role of elastases in chronic pancreatitis ......................................................... 8 3. Aims .................................................................................................................................. 10 3.1. ScheBo Pancreatic Elastase 1 Test Study .................................................................. 10 3.2. Genetic analysis study ............................................................................................... 10 4. Materials and methods .....................................................................................................
    [Show full text]
  • Transcriptomics of Cumulus Cells – a Window Into Oocyte Maturation in Humans Brandon A
    Wyse et al. Journal of Ovarian Research (2020) 13:93 https://doi.org/10.1186/s13048-020-00696-7 RESEARCH Open Access Transcriptomics of cumulus cells – a window into oocyte maturation in humans Brandon A. Wyse1*† , Noga Fuchs Weizman1†, Seth Kadish1, Hanna Balakier1, Mugundhine Sangaralingam1 and Clifford L. Librach1,2,3,4 Abstract Background: Cumulus cells (CC) encapsulate growing oocytes and support their growth and development. Transcriptomic signatures of CC have the potential to serve as valuable non-invasive biomarkers for oocyte competency and potential. The present sibling cumulus-oocyte-complex (COC) cohort study aimed at defining functional variations between oocytes of different maturity exposed to the same stimulation conditions, by assessing the transcriptomic signatures of their corresponding CC. CC were collected from 18 patients with both germinal vesicle and metaphase II oocytes from the same cycle to keep the biological variability between samples to a minimum. RNA sequencing, differential expression, pathway analysis, and leading-edge were performed to highlight functional differences between CC encapsulating oocytes of different maturity. Results: Transcriptomic signatures representing CC encapsulating oocytes of different maturity clustered separately on principal component analysis with 1818 genes differentially expressed. CCs encapsulating mature oocytes were more transcriptionally synchronized when compared with CCs encapsulating immature oocytes. Moreover, the transcriptional activity was lower, albeit not absent, in CC encapsulating mature oocytes, with 2407 fewer transcripts detected than in CC encapsulating immature (germinal vesicle - GV) oocytes. Hallmark pathways and ovarian processes that were affected by oocyte maturity included cell cycle regulation, steroid metabolism, apoptosis, extracellular matrix remodeling, and inflammation. Conclusions: Herein we review our findings and discuss how they align with previous literature addressing transcriptomic signatures of oocyte maturation.
    [Show full text]
  • Genetics of New-Onset Diabetes After Transplantation
    BASIC RESEARCH www.jasn.org Genetics of New-Onset Diabetes after Transplantation † † Jennifer A. McCaughan,* Amy Jayne McKnight,* and Alexander P. Maxwell* *Nephrology Research Group, Queen’s University, Belfast, Northern Ireland; and †Regional Nephrology Unit, Belfast City Hospital, Belfast, Northern Ireland ABSTRACT New-onset diabetes after transplantation is a common complication that reduces recipient survival. Research in renal transplant recipients has suggested that pancreatic b-cell dysfunction, as opposed to insulin resistance, may be the key pathologic process. In this study, clinical and genetic factors associated with new-onset diabetes after transplantation were identified in a white population. A joint analysis ap- proach, with an initial genome-wide association study in a subset of cases followed by de novo genotyping in the complete case cohort, was implemented to identify single-nucleotide polymorphisms (SNPs) asso- ciated with the development of new-onset diabetes after transplantation. Clinical variables associated with the development of diabetes after renal transplantation included older recipient age, female sex, and percentage weight gain within 12 months of transplantation. The genome-wide association study identi- fied 26 SNPs associated with new-onset diabetes after transplantation; this association was validated for eight SNPs (rs10484821, rs7533125, rs2861484, rs11580170, rs2020902, rs1836882, rs198372, and rs4394754) by de novo genotyping. These associations remained significant after multivariate adjustment for clinical variables. Seven of these SNPs are associated with genes implicated in b-cell apoptosis. These results corroborate recent clinical evidence implicating b-cell dysfunction in the pathophysiology of new- onset diabetes after transplantation and support the pursuit of therapeutic strategies to protect b cells in the post-transplant period.
    [Show full text]
  • Genetic Analysis of Human Chymotrypsin-Like
    International Journal of Molecular Sciences Article Genetic Analysis of Human Chymotrypsin-Like Elastases 3A and 3B (CELA3A and CELA3B) to Assess the Role of Complex Formation between Proelastases and Procarboxypeptidases in Chronic Pancreatitis Andrea Párniczky 1,†, Eszter Hegyi 1,†, Anna Zsófia Tóth 1, Ákos Szücs 2, Andrea Szentesi 3,4, Áron Vincze 5, Ferenc Izbéki 6, Balázs Csaba Németh 4, Péter Hegyi 3,4 and Miklós Sahin-Tóth 1,* 1 Center for Exocrine Disorders, Department of Molecular and Cell Biology, Boston University Henry M. Goldman School of Dental Medicine, Boston, MA 02118, USA; [email protected] (A.P.); [email protected] (E.H.); [email protected] (A.Z.T.) 2 First Department of Surgery, Semmelweis University, 1082 Budapest, Hungary; [email protected] 3 Institute for Translational Medicine, University of Pécs, 7624 Pécs, Hungary; [email protected] (A.S.); [email protected] (P.H.) 4 First Department of Medicine, University of Szeged, 6720 Szeged, Hungary; [email protected] 5 First Department of Medicine, University of Pécs, 7624 Pécs, Hungary; [email protected] 6 Department of Gastroenterology, St. George Teaching Hospital of County Fejér, 8000 Székesfehérvár, Hungary; fi[email protected] * Correspondence: [email protected]; Tel.: +1-617-414-1070; Fax: +1-617-414-1041 † These authors contributed equally to this work. Academic Editors: Srikumar Chellappan and Jaya Padmanabhan Received: 7 November 2016; Accepted: 14 December 2016; Published: 20 December 2016 Abstract: Human chymotrypsin-like elastases 3A and 3B (CELA3A and CELA3B) are the products of gene duplication and share 92% identity in their primary structure. CELA3B forms stable complexes with procarboxypeptidases A1 and A2 whereas CELA3A binds poorly due to the evolutionary substitution of Ala241 with Gly in exon 7.
    [Show full text]
  • Integrated Functional Genomic Analysis Enables Annotation of Kidney Genome-Wide Association Study Loci
    BASIC RESEARCH www.jasn.org Integrated Functional Genomic Analysis Enables Annotation of Kidney Genome-Wide Association Study Loci Karsten B. Sieber,1 Anna Batorsky,2 Kyle Siebenthall,2 Kelly L. Hudkins,3 Jeff D. Vierstra,2 Shawn Sullivan,4 Aakash Sur,4,5 Michelle McNulty,6 Richard Sandstrom,2 Alex Reynolds,2 Daniel Bates,2 Morgan Diegel,2 Douglass Dunn,2 Jemma Nelson,2 Michael Buckley,2 Rajinder Kaul,2 Matthew G. Sampson,6 Jonathan Himmelfarb,7,8 Charles E. Alpers,3,8 Dawn Waterworth,1 and Shreeram Akilesh3,8 Due to the number of contributing authors, the affiliations are listed at the end of this article. ABSTRACT Background Linking genetic risk loci identified by genome-wide association studies (GWAS) to their causal genes remains a major challenge. Disease-associated genetic variants are concentrated in regions con- taining regulatory DNA elements, such as promoters and enhancers. Although researchers have previ- ously published DNA maps of these regulatory regions for kidney tubule cells and glomerular endothelial cells, maps for podocytes and mesangial cells have not been available. Methods We generated regulatory DNA maps (DNase-seq) and paired gene expression profiles (RNA-seq) from primary outgrowth cultures of human glomeruli that were composed mainly of podo- cytes and mesangial cells. We generated similar datasets from renal cortex cultures, to compare with those of the glomerular cultures. Because regulatory DNA elements can act on target genes across large genomic distances, we also generated a chromatin conformation map from freshly isolated human glomeruli. Results We identified thousands of unique regulatory DNA elements, many located close to transcription factor genes, which the glomerular and cortex samples expressed at different levels.
    [Show full text]
  • Next-Generation Sequencing of Centenarians to Identify Genetic Variants
    Next-generation sequencing of centenarians to identify genetic variants predisposing to human longevity Dissertation In fulfillment of the requirements for the degree “Dr. rer. nat.” of the Faculty of Mathematics and Natural Sciences at Christian-Albrechts-Universität zu Kiel Submitted by Nandini Badarinarayan Research Group for Healthy Ageing Institute of Clinical Molecular Biology Kiel, July 2014 First referee: Prof. Dr. Tal Dagan Second referee: Prof. Dr. Almut Nebel th Date of oral examination: 24 October 2014 Signed: Prof. Dr. Wolfgang Duschl (Dean) “Always keep your smile. That's how I explain my long life.”- Jeanne Calment (who had the longest confirmed human lifespan in history, living to the age of 122 years, 164 days) For my family Contents I Table of Contents List of figures ...................................................................................... IV List of tables ..........................................................................................V List of abbreviations ........................................................................... VII 1 Introduction ............................................................................... 1 1.1 Longevity phenotype............................................................................... 1 1.2 Genetic epidemiology of human longevity ............................................. 4 1.3 Genetic influences on longevity .............................................................. 6 1.3.1 Findings in model organisms ....................................................................................
    [Show full text]